Bank of Montreal Can increased its stake in shares of Neogen Co. (NASDAQ:NEOG) by 80.1% during the 2nd quarter, Holdings Channel reports. The fund owned 89,671 shares of the company’s stock after purchasing an additional 39,889 shares during the quarter. Bank of Montreal Can’s holdings in Neogen were worth $4,175,000 as of its most recent filing with the Securities & Exchange Commission.
A number of other institutional investors and hedge funds have also modified their holdings of the business. The Manufacturers Life Insurance Company grew its holdings in Neogen by 98.6% in the second quarter. The Manufacturers Life Insurance Company now owns 175,249 shares of the company’s stock valued at $8,068,000 after purchasing an additional 86,998 shares during the period. Ergoteles LLC acquired a new stake in shares of Neogen in the second quarter worth approximately $668,000. Mitsubishi UFJ Trust & Banking Corp boosted its stake in shares of Neogen by 58.9% in the second quarter. Mitsubishi UFJ Trust & Banking Corp now owns 840,196 shares of the company’s stock worth $38,917,000 after acquiring an additional 311,408 shares during the last quarter. Xponance Inc. boosted its stake in shares of Neogen by 181.7% in the second quarter. Xponance Inc. now owns 18,026 shares of the company’s stock worth $830,000 after acquiring an additional 11,628 shares during the last quarter. Finally, Private Harbour Investment Management & Counsel LLC boosted its stake in shares of Neogen by 71.9% in the second quarter. Private Harbour Investment Management & Counsel LLC now owns 18,412 shares of the company’s stock worth $848,000 after acquiring an additional 7,702 shares during the last quarter. 92.00% of the stock is currently owned by institutional investors.
NEOG stock opened at $40.97 on Thursday. The company has a market capitalization of $4.40 billion, a PE ratio of 71.25 and a beta of 0.51. Neogen Co. has a 12-month low of $33.83 and a 12-month high of $48.85. The business’s fifty day moving average price is $42.83 and its 200 day moving average price is $36.89.
A number of analysts have recently issued reports on NEOG shares. TheStreet raised Neogen from a “c” rating to a “b-” rating in a research note on Thursday, July 8th. Zacks Investment Research downgraded Neogen from a “buy” rating to a “hold” rating and set a $45.00 price objective on the stock. in a research report on Monday, September 27th.
In other news, CFO Steven J. Quinlan sold 5,700 shares of the business’s stock in a transaction dated Wednesday, September 29th. The stock was sold at an average price of $44.05, for a total value of $251,085.00. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director James P. Tobin bought 1,000 shares of Neogen stock in a transaction dated Thursday, September 23rd. The stock was purchased at an average cost of $42.92 per share, with a total value of $42,920.00. The disclosure for this purchase can be found here. Insiders own 0.52% of the company’s stock.
Neogen Corp. engages in the development, manufacture, and sale of products dedicated to food and animal safety. It operates through the following segments: Food Safety and Animal Safety. The Food Safety segment consists of diagnostic test kits and related products used by food producers and processors to detect harmful natural toxins, foodborne bacteria, allergens, drug residues, and levels of general sanitation.
See Also: What is a management fee?
Want to see what other hedge funds are holding NEOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Neogen Co. (NASDAQ:NEOG).
Receive News & Ratings for Neogen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neogen and related companies with MarketBeat.com's FREE daily email newsletter.